Migdal Insurance & Financial Holdings’s First Trust Developed Markets ex-US AlphaDEX Fund FDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-71
Closed -$4K 390
2024
Q3
$4K Hold
71
﹤0.01% 361
2024
Q2
$4K Sell
71
-883
-93% -$49.2K ﹤0.01% 491
2024
Q1
$54K Sell
954
-1,023
-52% -$54.5K ﹤0.01% 273
2023
Q4
$104K Hold
1,977
﹤0.01% 258
2023
Q3
$99K Sell
1,977
-4,189
-68% -$219K ﹤0.01% 260
2023
Q2
$314K Sell
6,166
-1,534
-20% -$78.3K 0.01% 207
2023
Q1
$390K Sell
7,700
-900
-10% -$45.5K 0.01% 199
2022
Q4
$411K Sell
8,600
-68
-0.8% -$3.14K 0.01% 179
2022
Q3
$363K Sell
8,668
-392
-4% -$18.5K 0.01% 189
2022
Q2
$434K Sell
9,060
-5,280
-37% -$283K 0.01% 190
2022
Q1
$835K Buy
+14,340
New +$832K 0.01% 188

Other funds holding FDT

Migdal Insurance & Financial Holdings's FDT Position: Q4 2024 in Review

Migdal Insurance & Financial Holdings sold out of First Trust Developed Markets ex-US AlphaDEX Fund (FDT) in Q4 2024, closing a stake of 71 shares — an estimated $4K sold.

Migdal Insurance & Financial Holdings first reported a position in FDT in Q1 2022 and held it in 11 quarters. The position peaked at $835K in Q1 2022. 125 funds tracked by Wall St. Rank hold FDT as of Q4 2024.

  • Migdal Insurance & Financial Holdings reported no remaining First Trust Developed Markets ex-US AlphaDEX Fund position as of Q4 2024 after selling out during the quarter.
  • Migdal Insurance & Financial Holdings sold 71 First Trust Developed Markets ex-US AlphaDEX Fund shares in Q4 2024, an estimated $4K.
  • Migdal Insurance & Financial Holdings first reported a position in First Trust Developed Markets ex-US AlphaDEX Fund in Q1 2022 and held it in 11 quarters.
  • Migdal Insurance & Financial Holdings's First Trust Developed Markets ex-US AlphaDEX Fund position peaked at $835K in Q1 2022.
  • 125 funds tracked by Wall St. Rank held First Trust Developed Markets ex-US AlphaDEX Fund as of Q4 2024.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q4 2024, filed 28 Jan 2025.